瑞科生物-B2024年报

江蘇瑞科生物技術股份有限公司Jiangsu Recbio Technology Co., Ltd. ( a joint stock company incorporated in thePeople’s Republic of China with limited liability)Stock Code股份代號: 2179（於中華人民共和國註冊成立的股份有限公司） ANNUAL REPORT2024年 報 Contents 2Corporate Information6Chairman’s Statement9Financial Highlights10Management Discussion and Analysis40Biographies of Directors, Supervisors andSenior Management61Directors’ Report107Corporate Governance Report134Independent Auditor’s Report143Consolidated Statement of Profit or Loss andOther Comprehensive Income144Consolidated Statement of Financial Position146Consolidated Statement of Changes in Equity148Consolidated Statement of Cash Flows150Notes to Financial Statements254Definitions and Glossary of Technical Terms Corporate Information DIRECTORS1 Executive Directors Dr. LIU Yong(Chairman of the Board and General Manager)Mr. LI BuMs. CHEN QingqingDr. HONG Kunxue Non-executive Directors Dr. WANG RuweiDr. ZHANG JiaxinDr. ZHOU HongbinMr. HU Houwei Independent Non-executive Directors Dr. XIA LijunMr. LIANG GuodongProfessor GAO FengProfessor YUEN Ming Fai GAO Feng SUPERVISORS2 Ms. QIAO Weiwei(Chairwoman)Mr. WANG FeizhouMs. QIAN RantingMs. LIU Ping Dr. LIU Yong, Mr. LI Bu, Ms. CHEN Qingqing and Dr. HONGKunxue were appointed as executive Directors of the secondsession of the Board on May 8, 2024; Dr. WANG Ruwei, Dr.ZHANG Jiaxin, Dr. ZHOU Hongbin and Mr. HU Houwei wereappointed as non-executive Directors of the second session ofthe Board on May 8, 2024; Dr. XIA Lijun, Mr. LIANG Guodong,ProfessorGAOFengandProfessorYUENMingFaiwereappointedasindependentnon-executiveDirectorsofthesecond session of the Board on May 8, 2024; Dr. LIU YongwaselectedasthechairmanofthesecondsessionoftheBoard on May 8, 2024. Dr. CHEN Jianping ceased to serve asan executive Director on May 8, 2024.1 202458 Ms.QIAOWeiweiandMs.LIUPingwerere-electedasemployeerepresentativeSupervisorsofthesecondsessionof the Supervisory Board on May 7, 2024; Ms. QIAN RantingandMr.WANGFeizhouwereappointedasnon-employeerepresentativeSupervisorsofthesecondsessionoftheSupervisoryBoardonMay8,2024;Ms.QIAOWeiweiwasappointedasthechairwomanofthesecondsessionoftheSupervisory Board on May 8, 2024. Corporate Information JOINT COMPANY SECRETARIES3 Ms. CHEN QingqingMs. YUNG Mei Yee AUTHORISED REPRESENTATIVES Dr. LIU YongMr. LI Bu AUDIT COMMITTEE4 Dr. XIA Lijun(Chairman)Professor YUEN Ming FaiDr. ZHOU Hongbin REMUNERATION AND APPRAISAL COMMITTEE5 GAO FengProfessor YUEN Ming Fai(Chairman)Dr. XIA LijunMr. LIANG GuodongProfessor GAO FengMr. LI Bu NOMINATION COMMITTEE6 Dr. LIU Yong(Chairman)Professor GAO FengMr. LIANG GuodongDr. XIA Lijun 34563Ms.YUNGMeiYeewasappointedasajointcompanysecretary of the Company on June 18, 2024, and Ms. HO YinKwanceasedtoserveasajointcompanysecretaryoftheCompany on the same day.4Dr. XIA Lijun, Professor YUEN Ming Fai and Dr. ZHOU HongbinwereappointedasmembersoftheAuditCommitteeofthesecond session of the Board on May 8, 2024, with Dr. XIA Lijunserving as the chairman.5Professor YUEN Ming Fai, Dr. XIA Lijun, Mr. LI Bu, Mr. LIANGGuodongandProfessorGAOFengwereappointedasmembers of the Remuneration and Appraisal Committee of thesecond session of the Board on May 8, 2024, with ProfessorYUEN Ming Fai serving as the chairman.6Dr. LIU Yong, Dr. XIA Lijun, Mr. LIANG Guodong and ProfessorGAOFengwereappointedasmembersoftheNominationCommittee of the second session of the Board on May 8, 2024,with Dr. LIU Yong serving as the chairman. Corporate Information H SHARE REGISTRAR 1831717121716Computershare Hong Kong Investor Services LimitedShops 1712-1716, 17th FloorHopewell Centre183 Queen’s Road EastWan ChaiHong Kong HEAD OFFICE AND REGISTERED OFFICE IN THE PRC 888No. 888 Yaocheng AvenueMedical High-tech DistrictTaizhou CityJiangsu Provincethe PRC PRINCIPAL PLACE OF BUSINESS IN HONG KONG 2484040th Floor, Dah Sing Financial CentreNo.248 Queen’s Road EastWan ChaiHong Kong PRINCIPAL BANK China Merchants Bank Co., Ltd.Taizhou BranchBuilding 10, No. 293, Gulou South RoadHailing DistrictTaizhou CityJiangsu Province, the PRC 29310 Corporate Information HONG KONG LEGAL ADVISOR Clifford Chance27/F, Jardine HouseOne Connaught PlaceHong Kong PRC LEGAL ADVISOR Zhong Lun Law Firm22-31/F, South Tower of CP Center20 Jin He East AvenueChaoyang DistrictBeijing, the PRC AUDITOR Ernst & YoungCertified Public AccountantsRegistered Public Interest Entity Auditor27/F, One Taikoo Place979 King’s RoadQuarry Bay, Hong Kong COMPANY’S WEBSITE www.recbio.cnwww.recbio.cn STOCK CODE 21792179 Chairman’s Statement Dear Shareholders, In2024,thebiopharmaceuticalindustryasawholecontinuedto present a complex situation of challenges and opportunities.Facing the external pressure, Recbio people have always adheredto the original inspiration of “developing the first class vaccinesto protect human health” and the development principle of “valuecreation”,withaviewtoaccumulatingvigorousdevelopmentpotential in the recession and welcoming the val